CD8A and neoplasm: TAMs recruit immunosuppressive cells such as regulatory T cells (Tregs) and myeloid-derived suppressor cells (MDSCs), and inhibit the function of anti-tumor immune cells such as CD8+ T cells and natural killer cells [8–10].